Tumor specific antigens (TSAs) are prevalent targets in the development of anticancer immunotherapies and vaccines. The translation of a chimeric RNA product that joins transposable element sequence with gene sequence (TE-chimeric transcript) could contribute to the formation of a new protein against oncogenesis. These TE-chimeric transcripts have served as new potential biomarkers and promising therapeutic targets for cancer therapy. Here, we present the SCAR_TSA module that allows users to screen TE-chimeric transcripts in 10357 tumors.